Results 21 to 30 of about 5,339,936 (244)

Detection Methods and Clinical Applications of Circulating Tumor Cells in Breast Cancer

Frontiers in Oncology, 2021
Circulating Tumor Cells (CTCs) are cancer cells that split away from the primary tumor and appear in the circulatory system as singular units or clusters, which was first reported by Dr. Thomas Ashworth in 1869.
Hongyi Zhang, Xiaoyan Lin, Yuan Huang, Minghong Wang, Chunmei Cen, Shasha Tang, Marcia R. Dique, Lu Cai, Manuel A. Luis, Jillian Smollar, Yuan Wan, Fengfeng Cai   +11 more
doaj   +1 more source

Integration of biomimicry and nanotechnology for significantly improved detection of circulating tumor cells (CTCs) [PDF]

Advanced Drug Delivery Reviews, 2018
Seungpyo Hong, Az Wang, Ja Hye Myung
exaly   +2 more sources

The importance of circulating tumor products as „liquid biopsies” in colorectal cancer

Journal of Mind and Medical Sciences, 2018
Liquid biopsies represent an array of plasma analysis tests that are studied to evaluate and identify circulating tumor products, especially circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA).
Alina Miscoci, Cristian D. Pirvu, Veronica Calborean, Costin T. Streba, Otilia C. Rogoveanu, Vlad Pădureanu, Cristin C. Vere   +6 more
doaj   +1 more source

Clinical value of circulating tumor cells and hematological parameters in 617 Chinese patients with colorectal cancer: retrospective analysis

BMC Cancer, 2023
Background Circulating tumor cells (CTCs) have been a non-invasive technique which allows investigation of tumor characteristics. The purpose of this study was to investigate the relationship between circulating tumor cells and colorectal cancer. Methods
Yuhao He, Xinxin He, Yubo Zhou, Shanshan Luo   +3 more
doaj   +1 more source

Detection of Tumor Cell-Specific mRNA in the Peripheral Blood of Patients with Breast Cancer-Evaluation of Several Markers with Real-Time Reverse Transcription-PCR [PDF]

, 2013
It is widely known that cells from epithelial tumors, e. g., breast cancer, detach from their primary tissue and enter blood circulation. We show that the presence of circulating tumor cells (CTCs) in samples of patients with primary and metastatic ...
Simone Hofmann, Kölbl, Alexandra C., Jeschke, Udo, Klaus Friese, Andergassen, Ulrich, Neugebauer, Julia, Alexandra Kölbl, Udo Jeschke, Matthias Ilmer, Julia Neugebauer, Ilmer, Matthias, Ulrich Andergassen, Engelstädter, Verena, Schindlbeck, Christian, Hofmann, Simone, Hutter, Stefan, Stefan Hutter, Ra C. Kölbl, Friese, Klaus, Verena Engelstädter, Christian Schindlbeck   +20 more
core   +1 more source

A comparative study on ctDNA and tumor DNA mutations in lung cancer and benign cases with a high number of CTCs and CTECs

Journal of Translational Medicine, 2023
Background Liquid biopsy provides a non-invasive approach that enables detecting circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs) using blood specimens and theoretically benefits early finding primary tumor or monitoring treatment ...
Jianzhu Xie, Binjie Hu, Yanping Gong, Sijia He, Jun Lin, Qian Huang, Jin Cheng   +6 more
doaj   +1 more source

Recent Update Roles of Magnetic Nanoparticles in Circulating Tumor Cell (CTC)/Non-CTC Separation

Pharmaceutics, 2023
Metastasis of cancer is a major cause of death worldwide. Circulating tumor cells (CTCs) are important in the metastatic process of cancer. CTCs are able to circulate in the bloodstream. Therefore, they can be used as biomarkers of metastasis. However, CTCs are rare when compared to a large number of blood cells in the blood. Many CTC detection methods
Chawapon Pipatwatcharadate, Poornima Ramesh Iyer, Dakrong Pissuwan   +2 more
openaire   +3 more sources

Cultured circulating tumor cells and their derived xenografts for personalized oncology

Asian Journal of Urology, 2016
Recent cancer research has demonstrated the existence of circulating tumor cells (CTCs) in cancer patient's blood. Once identified, CTC biomarkers will be invaluable tools for clinical diagnosis, prognosis and treatment.
Ruoxiang Wang, Gina C.Y. Chu, Stefan Mrdenovic, Alagappan A. Annamalai, Andrew E. Hendifar, Nicholas N. Nissen, James S. Tomlinson, Michael Lewis, Nallasivam Palanisamy, Hsian-Rong Tseng, Edwin M. Posadas, Michael R. Freeman, Stephen J. Pandol, Haiyen E. Zhau, Leland W.K. Chung   +14 more
doaj   +1 more source

The potential for liquid biopsies in the precision medical treatment of breast cancer

Cancer Biology & Medicine, 2016
Currently the clinical management of breast cancer relies on relatively few prognostic/predictive clinical markers (estrogen receptor, progesterone receptor, HER2), based on primary tumor biology.
Victoria A. Forte, Dany K. Barrak, Mostafa Elhodaky, Lily Tung, Anson Snow, Julie E. Lang   +5 more
doaj   +1 more source

How to Agree on a CTC: Evaluating the Consensus in Circulating Tumor Cell Scoring [PDF]

Cytometry Part A, 2018
AbstractFor using counts of circulating tumor cells (CTCs) in the clinic to aid a physician's decision, its reported values will need to be accurate and comparable between institutions. Many technologies have become available to enumerate and characterize CTCs, thereby showing a large range of reported values.
Zeune, Leonie L.; de Wit, Sanne; Berghuis, A. M. Sofie; Ijzerman, Maarten J.; Terstappen, Leon W. M. M.; Brune, Christoph   +6 more
openaire   +4 more sources